CN1083714A - A kind of cancer therapy drug of Chinese medicinal components - Google Patents

A kind of cancer therapy drug of Chinese medicinal components Download PDF

Info

Publication number
CN1083714A
CN1083714A CN 93106194 CN93106194A CN1083714A CN 1083714 A CN1083714 A CN 1083714A CN 93106194 CN93106194 CN 93106194 CN 93106194 A CN93106194 A CN 93106194A CN 1083714 A CN1083714 A CN 1083714A
Authority
CN
China
Prior art keywords
radix
rhizoma
chinese medicine
semen
carcinoma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 93106194
Other languages
Chinese (zh)
Inventor
曾纪感
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 93106194 priority Critical patent/CN1083714A/en
Publication of CN1083714A publication Critical patent/CN1083714A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to the field of preparing medicines, be particularly related to cancer therapy drug, 29 flavor Chinese medicine powders such as dress Rhizoma Arisaematis in it is assisted by medicinal little arogel, confused, the Rhizoma Polygoni Cuspidati of blooming are formed, the effect of have heat-clearing and toxic substances removing, removing blood stasis to reduce swelling, activating collaterals and eliminating stagnation, curing the disease, for pulmonary carcinoma, uterus carcinoma, ovarian cancer, the brain cancer, esophageal carcinoma, laryngeal carcinoma etc. better curative effect is arranged all, and be Chinese medicine west system, and a kind of anticancer drugs that have Chinese medicine and Western medicine advantage simultaneously.

Description

A kind of cancer therapy drug of Chinese medicinal components
The present invention relates to the field of preparing medicines.
Up to the present, multiple cancer therapy drug is arranged in the world, but all have the curative effect problem or take after pay problems in role, and less the guidance from theory of Chinese medical science prepares medicines, the patent medicine of Chinese medicine west system still less, and Chinese medicine anticancer, that control cancer is confined to decoction, powder state in the past, no matter be from the grasp of dosage or taking the aspect all has difficulties, existing in addition cancer therapy drug mostly is the killing or suppress growth of cancerous cell, wait to pay acts on but simultaneously normal cell has also been produced to kill, and universal is less.More do not utilize theory of Chinese medical science people's body to be carried out comprehensively regulating from dialectical view.There is significant limitation.
The objective of the invention is to: a kind of heat-clearing and toxic substances removing is provided, removing blood stasis to reduce swelling, activating collaterals and eliminating stagnation, spleen invigorating is regulated the flow of vital energy, and is the anticancer drugs of component by Chinese medicine, and through Chinese medicine is made powdery, Chinese medicine west pharmacy product in quantitatively incapsulating make this medicine not only to various cancers therapeutical effect preferably be arranged, and the comprehensively regulating of pair person are arranged, make because the poison that chemotherapy produces is paid effect, the huge pain of health of patients with advanced cancer etc. has mitigation.
The component of cancer therapy drug of the present invention is: (% is a total weight percent)
Rhizoma Arisaematis 2.4%~3% Radix Trichosanthis 2.4%~3%
The Rhizoma Pinelliae 2.4%~3% Radix Salviae Miltiorrhizae 2.4%~3%
Radix Sophorae Tonkinensis 2.4%~3% stir-baked SQUAMA MANITIS 2.4%~3%
Carapax Trionycis 2.4%~3% Radix Scrophulariae 2.4%~3%
Rhizoma Paridis 2.4%~3% Rhizoma Dioscoreae Septemlobae 2.4%~3%
The Pseudobulbus Bletillae (Rhizoma Bletillae) 2.4%~3% Radix Asparagi 3.2%~4%
Radix Ophiopogonis 3.2%~4% Radix Stemonae 3.2%~4%
Radix Platycodonis 3.2%~4% Herba Houttuyniae 3.2%~4%
The Radix Astragali 3.2%~4% Rhizoma Polygoni Cuspidati 4.8%~6%
Herba Scutellariae Barbatae 4.8%~6% Spica Prunellae 8%~10%
Herba Hedyotidis Diffusae 8%~10% Sargassum 8%~10%
Rhizoma Smilacis Glabrae 2.4%~3% Radix Et Rhizoma Rhei 0.9%~1.1%
Semen Arecae 1.6%~2% Semen Pharbitidis 1.8%~2%
Nidus Vespae 1.8%~2% Endothelium Corneum Gigeriae Galli 1.8%~2.2%
System Semen Strychni 0.22%~0.3%
Semen Arecae in the above component and Semen Pharbitidis can replace with the equivalent Polyporus.
When preparation medicine of the present invention, can follow these steps to carry out:
1, with Endothelium Corneum Gigeriae Galli, stir-baked SQUAMA MANITIS, Semen Strychni (processed), Rhizoma Paridis and Rhizoma Arisaematis are ground into fine powder, cross 100 mesh sieve standbies.
2, all the other medicament mixed, clear water is cleaned, and washes in a pan and removes silt, contains in the stainless-steel pan, adds water three sesquialters, puts on the stove fire, and slow fire boiling one hour leaches medicine juice, adds the water half as much again again, and slow fire boiling one hour leaches medicine juice, removes slag.Mix frying in shallow oil juice for twice again, filter in the stainless-steel pan, put that slow fire boiling becomes paste on the stove fire, take out solarization or oven dry or spray drying with gauze.Be ground into fine powder, cross 100 mesh sieves.
3, above two kinds of powder are contained in the blender, stirred 6~8 minutes, make it abundant mix homogeneously, incapsulate with 0.5 gram then.The invention has the advantages that medicine is that kinds of traditional Chinese medicines is made capsulation, so more convenient than Chinese medicine on taking.
And the present invention has heat-clearing and toxic substances removing, eliminating stasis and resolving masses, and the function that spleen invigorating is regulated the flow of vital energy, to pulmonary carcinoma, uterus carcinoma, ovarian cancer, the brain cancer, esophageal carcinoma, laryngeal carcinoma disease, bladder cancer, nasopharyngeal carcinoma, waiting all has better curative effect, and stronger analgesic activity is arranged, and is comparatively effectively medicine of anti-curing cancers.
The present invention can be achieved by the following example.
Embodiment 1: prepare by following Chinese drug-treated group part: (% is a total weight percent)
Rhizoma Arisaematis 2.4% Radix Trichosanthis 2.4%
The Rhizoma Pinelliae 2.8% Radix Salviae Miltiorrhizae 2.8%
Radix Sophorae Tonkinensis 2.8% stir-baked SQUAMA MANITIS 2.8%
Carapax Trionycis 2.8% Radix Scrophulariae 2.8%
Rhizoma Paridis 2.8% Rhizoma Dioscoreae Septemlobae 2.8%
The Pseudobulbus Bletillae (Rhizoma Bletillae) 2.8% Radix Asparagi 3.2%
Radix Ophiopogonis 3.2% Radix Stemonae 3.2%
Radix Platycodonis 3.2% Herba Houttuyniae 3.2%
The Radix Astragali 3.2% Rhizoma Polygoni Cuspidati 4.8%
Herba Scutellariae Barbatae 4.8% Spica Prunellae 10%
Herba Hedyotidis Diffusae 10% Sargassum 10%
Rhizoma Smilacis Glabrae 2.4% Radix Et Rhizoma Rhei 1.1%
Semen Arecae 2% Semen Pharbitidis 1.8%
Nidus Vespae 1.8% Endothelium Corneum Gigeriae Galli 1.8%
System Semen Strychni 0.3%
Embodiment 2: prepare by following Chinese drug-treated group part: (% is a total weight percent)
Rhizoma Arisaematis 2.8% Radix Trichosanthis 2.8%
The Rhizoma Pinelliae 2.5% Radix Salviae Miltiorrhizae 2.5%
Radix Sophorae Tonkinensis 2.5% stir-baked SQUAMA MANITIS 2.5%
Carapax Trionycis 2.5% Radix Scrophulariae 2.5%
Rhizoma Paridis 2.5% Rhizoma Dioscoreae Septemlobae 2.5%
The Pseudobulbus Bletillae (Rhizoma Bletillae) 2.5% Radix Asparagi 4%
Radix Ophiopogonis 4% Radix Stemonae 4%
Radix Platycodonis 4% Herba Houttuyniae 4%
The Radix Astragali 4% Rhizoma Polygoni Cuspidati 6%
Herba Scutellariae Barbatae 6% Spica Prunellae 8%
Herba Hedyotidis Diffusae 8% Sargassum 8%
Rhizoma Smilacis Glabrae 3% Radix Et Rhizoma Rhei 0.95%
Semen Arecae 1.6% Semen Pharbitidis 2%
Nidus Vespae 2% Endothelium Corneum Gigeriae Galli 2.1%
System Semen Strychni 0.25%
Semen Arecae in the above component and Semen Pharbitidis can replace with the equivalent Polyporus.
When preparation medicine of the present invention, can follow these steps to carry out:
1, with Endothelium Corneum Gigeriae Galli, stir-baked SQUAMA MANITIS, Semen Strychni (processed), Rhizoma Paridis and Rhizoma Arisaematis are ground into fine powder, 100 mesh sieve standbies.
2, all the other medicament mixed, clear water is cleaned, and washes in a pan and removes silt, contains in the stainless-steel pan, adds water three sesquialters, puts on the stove fire, and slow fire boiling one hour leaches medicine juice, adds the water half as much again again, and slow fire boiling one hour leaches medicine juice, removes slag.Mix frying in shallow oil juice for twice again, filter in the stainless-steel pan, put that slow fire boiling becomes paste on the stove fire, take out solarization or oven dry or spray drying with gauze.Be ground into fine powder, cross 100 mesh sieves.
3。Above two kinds of powder are contained in the blender, stirred 6~8 minutes, make it abundant mix homogeneously, incapsulate with 0.5 gram then.

Claims (2)

1, a kind of cancer therapy drug of being made up of Chinese medicine is that the powder that the dress kinds of traditional Chinese medicines is made in the medicinal Caplet is formed, and it is characterized in that the Chinese medicine component is: (% is a total weight percent)
Rhizoma Arisaematis 2.4%~3% Radix Trichosanthis 2.4%~3%
The Rhizoma Pinelliae 2.4%~3% Radix Salviae Miltiorrhizae 2.4%~3%
Radix Sophorae Tonkinensis 2.4%~3% stir-baked SQUAMA MANITIS 2.4%~3%
Carapax Trionycis 2.4%~3% Radix Scrophulariae 2.4%~3%
Rhizoma Paridis 2.4%~3% Rhizoma Dioscoreae Septemlobae 2.4%~3%
The Pseudobulbus Bletillae (Rhizoma Bletillae) 2.4%~3% Radix Asparagi 3.2%~4%
Radix Ophiopogonis 3.2%~4% Radix Stemonae 3.2%~4%
Radix Platycodonis 3.2%~4% Herba Houttuyniae 3.2%~4%
The Radix Astragali 3.2%~4% Rhizoma Polygoni Cuspidati 4.8%~6%
Herba Scutellariae Barbatae 4.8%~6% Spica Prunellae 8%~10%
Serpentis SHECAO 8%~10% Sargassum 8%~10%
Poria 2.4%~3% Radix Et Rhizoma Rhei 0.9%~1.1%
Semen Arecae 1.6%~2% Semen Pharbitidis 1.8%~2%
Nidus Vespae 1.8%~2% Endothelium Corneum Gigeriae Galli 1.8%~2.2%
System Semen Strychni 0.22%~0.3%
2, according to claim 1, of the present invention levying is that Semen Arecae and Semen Pharbitidis can replace with the equivalent Polyporus.
CN 93106194 1993-05-18 1993-05-18 A kind of cancer therapy drug of Chinese medicinal components Pending CN1083714A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 93106194 CN1083714A (en) 1993-05-18 1993-05-18 A kind of cancer therapy drug of Chinese medicinal components

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 93106194 CN1083714A (en) 1993-05-18 1993-05-18 A kind of cancer therapy drug of Chinese medicinal components

Publications (1)

Publication Number Publication Date
CN1083714A true CN1083714A (en) 1994-03-16

Family

ID=4986117

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 93106194 Pending CN1083714A (en) 1993-05-18 1993-05-18 A kind of cancer therapy drug of Chinese medicinal components

Country Status (1)

Country Link
CN (1) CN1083714A (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1057690C (en) * 1996-10-18 2000-10-25 宁振峰 Chinese Patent medicine
CN1058882C (en) * 1996-09-24 2000-11-29 来春荣 Oral liquor for treating tumour and disease of liver, and preparation method thereof
CN1060659C (en) * 1995-12-22 2001-01-17 徐瑞新 Pill medicine for cancer and preparation method
CN1305513C (en) * 2005-10-27 2007-03-21 吴军杰 Broad-spectrum cancer-treating Chinese medicine prepn and its prepn process
CN100518789C (en) * 2007-03-09 2009-07-29 阮玉江 Medicine for treating cancer and preparing method therefor
CN103417877A (en) * 2012-05-23 2013-12-04 余长成 Cancer treatment and prevention by utilization of herbal medicine
US10172904B2 (en) * 2008-09-25 2019-01-08 Lifebiotic Medical Research Ltd Herbal formulations

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1060659C (en) * 1995-12-22 2001-01-17 徐瑞新 Pill medicine for cancer and preparation method
CN1058882C (en) * 1996-09-24 2000-11-29 来春荣 Oral liquor for treating tumour and disease of liver, and preparation method thereof
CN1057690C (en) * 1996-10-18 2000-10-25 宁振峰 Chinese Patent medicine
CN1305513C (en) * 2005-10-27 2007-03-21 吴军杰 Broad-spectrum cancer-treating Chinese medicine prepn and its prepn process
CN100518789C (en) * 2007-03-09 2009-07-29 阮玉江 Medicine for treating cancer and preparing method therefor
US10172904B2 (en) * 2008-09-25 2019-01-08 Lifebiotic Medical Research Ltd Herbal formulations
CN103417877A (en) * 2012-05-23 2013-12-04 余长成 Cancer treatment and prevention by utilization of herbal medicine

Similar Documents

Publication Publication Date Title
CN1132643A (en) Medicine for diseases of liver and gall
CN1895619A (en) Chinese-medicinal composition for preventing and treating liver disease and its preparation
CN1083714A (en) A kind of cancer therapy drug of Chinese medicinal components
CN1290550C (en) Chinese medicine composition for treating rheumatism, rheumatoid, hyperosteogeny and fracture and preparing method thereof
CN1250264C (en) Capsule for curing hyperplasia of mammary glands and its preparation method
CN1294015A (en) Medicine for treating thyroid enlargement and thyroidism
CN1061552C (en) Epilepsy recovering pill and preparing process thereof
CN1298362C (en) Compound Chinese medicine prepn for treating pulvic infection and its prepn process
CN1785391A (en) Chinese medicinal composition and its preparation method
CN1050051C (en) "Dianjiankang" - a Chinese proprietary medicine for treatment of epilepsy
CN1223886A (en) Pathogenic factor eliminating and healthy energy supporting anticancer medicine
CN1136939A (en) Chinese drugs for curing hepatitis B
CN1074292C (en) Cancer treating medicine capsule
CN1158091C (en) Chinese medicine composition for treating lung cancer
CN1086129C (en) Hepatitis restoration pill
CN1249191A (en) Powdered medicine for treating vasculitis and its preparing process
CN1449773A (en) Chinese patent drug for treating gastric ulcer and its preparation method
CN1130529A (en) Aizikangfuning-Chinese patent drug for treating AIDS and preparing process thereof
CN1356117A (en) Capsule 'Tangniaoshenkang' for treating diabetes
CN1186036C (en) Diabetes treating medicine and its prepn
CN1063077C (en) Traditional Chinese medicine composition for lowering blood-lipid, and method for preparing same
CN1259956C (en) Chinese medicine composition for treating heart, kidney and multiple-organ failure and its prepn
CN1127968C (en) Oral powder medicine Xiaobaisan for treating leukotrichia and its preparation method
CN1334114A (en) Chinese medicine for treating mastoplasia
CN1144123A (en) Prescription of Xinmaitai and its production process

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication